Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine for patients with MDR-TB: Table 1.

27 Oct 2015

Abstract excerpt

The emergence of MDR-TB is a cause of great concern due to difficulties in patient management and poor treatment outcomes. Currently the duration of treatment and the choice of drugs for patients with MDR-TB are standardized in many countries. This might not be the best approach since the optimal therapy may depend on different pathogen- and host-related features. Combining the introduction of technological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pneumocystis jirovecii pneumonia detection and treatment
Share to Pneumonia and Respiratory Infections
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26507429
DOI: 10.1093/jac/dkv354

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine for patients with MDR-TB: Table 1.PMID 26507429Read ↗

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort StudySemantic proximity Read ↗

[Emerging and drug-resistant infectious diseases--multi-drug resistant tuberculosis].Semantic proximity Read ↗

Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.Semantic proximity Read ↗

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized careSemantic proximity Read ↗

Drug‐resistant tuberculosis: Past, present, futureSemantic proximity Read ↗

Multidrug-resistant tuberculosis.Semantic proximity Read ↗

Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencingSemantic proximity Read ↗

Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.Semantic proximity Read ↗

Characteristics and Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis at Abbassia Chest Hospital: A Tertiary Chest Facility in Cairo, EgyptSemantic proximity Read ↗

Assessment of Antibiotic Resistance and Associated Factors in Patients with Tuberculosis: A Nationwide Cross-Sectional Study of Indonesian TB-DRSSemantic proximity Read ↗

Rapid Molecular Assays for the Diagnosis of Drug-Resistant TuberculosisSemantic proximity Read ↗

Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South AfricaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.